Your browser doesn't support javascript.
loading
Structure-activity relationship study of DEL-22379: ERK dimerization inhibitors with increased safety.
Yang, Yang; Zhou, Yuanzheng; Tao, Lei; Yang, Tao; Zhao, Yinglan; Luo, Youfu.
Affiliation
  • Yang Y; Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
  • Zhou Y; Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
  • Tao L; Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
  • Yang T; Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
  • Zhao Y; Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Luo Y; Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China. zhaoyinglan@scu.edu.cn.
Mol Divers ; 25(2): 1051-1075, 2021 May.
Article in En | MEDLINE | ID: mdl-32377992
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Indoles / Antineoplastic Agents Limits: Animals / Female / Humans / Male Language: En Journal: Mol Divers Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Indoles / Antineoplastic Agents Limits: Animals / Female / Humans / Male Language: En Journal: Mol Divers Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country: China